Natural Capsules Q4 FY26 Revenue ₹58.45 Cr, PAT (₹4.98 Cr)

Natural Capsules Limited announced its audited financial results for Q4 and the full year ended March 31, 2026. For Q4 FY26, the company reported a revenue of ₹58.45 Cr and a PAT of (₹4.98 Cr). For the full year FY26, revenue stood at ₹187.20 Cr with a PAT of (₹24.66 Cr). Mr. Sunil Mundra, Executive Director, highlighted Q4 as a strong operational quarter, driven by successful dispatch of goods deferred due to a prior plant shutdown. The incremental HPMC line for double-zero capsules is ready, with revenue expected from H2 FY27. Commercial sales for the API business commenced in Q4 FY26. The subsidiary, Natural Biogenex Private Limited, partnered with Fermbox Bio Private Limited to enhance fermentation-based CDMO capabilities and create new revenue streams. The company aims for optimal capacity utilization, improved operational efficiency in capsules, and scaling the API business in FY27.